PROSPECTO: INFORMATION FOR THE USER
Azitromicina Combix 500 mg film-coated tablets EFG
Azitromycin (as dihydrate)
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
Azitromicina belongs to a group of medicines called macrolide antibiotics. It is used to treat infections caused by microorganisms such as bacteria. These infections include:
Do not take Azitromicina Combix
Warnings and precautions
Consult your doctor or pharmacist before starting to take Azitromicina Combix.
Be especially careful with Azitromicina Combix
Before starting treatment with this medication, inform your doctor if:
If you experience severe or persistent diarrhea during or after treatment, particularly if you notice blood or mucus, you should inform your doctor immediately.
If symptoms persist after completing treatment with azithromycin, or if you notice new persistent symptoms, contact your doctor.
Use of Azitromicina with other medications
Consult your doctor if you are taking any of the following medications:
Inform your doctor or pharmacist if you are using or have recently used other medications, even those purchased without a prescription.
Pregnancy and breastfeeding
The available information on the safety of azithromycin during pregnancy is insufficient. Therefore, azithromycin is not recommended if you are pregnant or trying to become pregnant. However, your doctor may decide to prescribe it under grave circumstances.
You should not breastfeed while taking azithromycin, as it may cause adverse reactions in the infant, including diarrhea and infections. You may resume breastfeeding two days after stopping treatment with azithromycin.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
Azithromycin may cause dizziness and seizures. If this is your case, do not drive or operate machinery.
Azitromicina Combix contains lactose.If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions for azitromicina as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The tablets should be swallowed preferably with water, they can be taken with or without food.
The recommended dose is:
Adults (including elderly patients) and children over 45 kg of weight:
The usual dose is 1,500 mg divided over 3 or 5 days in the following way:
Patients with renal or hepatic impairments:
You must inform your doctor immediately if you have kidney or liver problems as this may require modification of the usual dose.
Use in children and adolescents
Children and adolescents under 45 kg of weight:
The tablets are not indicated for these patients. Other pharmaceutical forms of azitromicina medications (e.g. suspensions) may be used.
If you take more Azitromicina Combix than you should
If you (or another person) ingest many tablets at once, or if you believe a child has ingested any of the tablets, contact your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount used. It is recommended to bring the packaging and leaflet to the healthcare professional. A overdose may cause reversible hearing loss, intense nausea (sensation of dizziness), vomiting, and diarrhea.
If you forget to take Azitromicina Combix
If you forget to take a tablet, take it as soon as possible, unless it is almost time for the next dose.
Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Azitromicina Combix
Do not stop taking the medication without consulting your doctor first, even if you feel better. It is essential to continue taking azitromicina for the indicated period of time as prescribed by your doctor, as this may prevent the infection from recurring.
If you have any other questions about the use of this medication, consult your doctor or pharmacist.
Like all medicines, azithromycin can cause side effects, although not everyone will experience them.
If you notice any of these side effects, stop taking the tablets and inform your doctor immediately or visit the nearest emergency service:
These are rare but very serious side effects. You may require urgent medical attention or hospitalization.
The following side effects have been reported:
Frequent (can affect up to 1 in 10 patients):
Infrequent (can affect up to 1 in 100 patients):
Rare (can affect up to 1 in 1,000 patients):
The frequency of the following side effects is unknown:
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions. Do not change the tablets to another container.
Do not use this medication after the expiration date that appears on the container after “Cad.” The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Azitromicina Combix
- The active ingredient is azithromycin. Each tablet contains 500 mg of azithromycin (as azithromycin dihydrate).
- The other components are: maize pregelatinized starch, crospovidone, anhydrous calcium hydrogen phosphate, sodium lauryl sulfate, magnesium stearate, hypromellose, titanium dioxide (E-171), lactose monohydrate, glyceryl triacetate.
Appearance of the product and contents of the package
Azitromicina Combix 500 mg is presented in the form of film-coated tablets, white in color, oblong, biconvex, marked on one face.
Each package contains blisters with 3 or 150 tablets.
It is possible that not all sizes will be marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Combix, S.L.U. Laboratories
C/ Badajoz 2, Edificio 2
28223- Pozuelo de Alarcon (Madrid)
Spain
Responsible for manufacturing:
Bluepharma - Indústria Farmacêutica, S.A.
S. Martinho do Bispo. 3045-016 Coimbra
Portugal
This prospectus was approved in March 2018.
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.